M Veronese

1.3k total citations
21 papers, 1.2k citations indexed

About

M Veronese is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, M Veronese has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in M Veronese's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). M Veronese is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). M Veronese collaborates with scholars based in Australia, United States and Italy. M Veronese's co-authors include Michael E. McManus, John O. Miners, Linda C. Quattrochi, Donald Birkett, Wendy Burgess, Wichittra Tassaneeyakul, Anthony C. Huggett, R H Tukey, Robert H. Tukey and Lloyd Sansom and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M Veronese

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Veronese Australia	14	788	440	379	189	116	21	1.2k
G. Gordon Gibson United Kingdom	18	710 0.9×	489 1.1×	370 1.0×	108 0.6×	101 0.9×	38	1.4k
Masayuki Komori Japan	24	952 1.2×	732 1.7×	424 1.1×	204 1.1×	139 1.2×	70	1.7k
Mitsukazu Kitada Japan	23	1.3k 1.6×	588 1.3×	555 1.5×	212 1.1×	134 1.2×	80	1.9k
Toshifumi Aoyama United States	9	898 1.1×	282 0.6×	377 1.0×	130 0.7×	129 1.1×	9	1.2k
Deborah Dunbar United States	18	789 1.0×	274 0.6×	510 1.3×	102 0.5×	145 1.3×	25	1.3k
L R Pohl United States	23	747 0.9×	356 0.8×	218 0.6×	122 0.6×	178 1.5×	42	1.5k
F. Peter Guengerich United States	12	864 1.1×	670 1.5×	360 0.9×	353 1.9×	108 0.9×	14	1.7k
Jean-Pierre Flinois France	21	805 1.0×	405 0.9×	433 1.1×	96 0.5×	98 0.8×	31	1.4k
T. Wolff Germany	18	944 1.2×	412 0.9×	485 1.3×	353 1.9×	129 1.1×	33	1.6k
Bing-Kou Tang Canada	15	828 1.1×	324 0.7×	421 1.1×	162 0.9×	283 2.4×	16	1.5k

Countries citing papers authored by M Veronese

Since Specialization

Citations

This map shows the geographic impact of M Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Veronese more than expected).

Fields of papers citing papers by M Veronese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Veronese. The network helps show where M Veronese may publish in the future.

Co-authorship network of co-authors of M Veronese

This figure shows the co-authorship network connecting the top 25 collaborators of M Veronese. A scholar is included among the top collaborators of M Veronese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Veronese. M Veronese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greco, Salvatore, et al.. (2024). Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study. Cardiovascular Diabetology. 23(1). 153–153. 2 indexed citations

Tassaneeyakul, Wichittra, Donald Birkett, John W. Edwards, et al.. (1996). Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 101–108. 19 indexed citations

Miners, John O., et al.. (1995). Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.. Journal of Pharmacology and Experimental Therapeutics. 272(3). 1076–1081. 62 indexed citations

Veronese, M, Wendy Burgess, Xiaoyi Zhu, & Michael E. McManus. (1994). Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochemical Journal. 302(2). 497–502. 49 indexed citations

Sansom, Lloyd, et al.. (1993). CDNA Expression Studies of Rat Liver Aryl Sulfotransferase. Biochemical and Biophysical Research Communications. 191(1). 295–301. 13 indexed citations

Tassaneeyakul, Wichittra, Donald Birkett, M Veronese, et al.. (1993). Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.. Journal of Pharmacology and Experimental Therapeutics. 265(1). 401–407. 293 indexed citations

Zhu, Xiaoyi, et al.. (1993). Identification of Two Human Brain Aryl Sulfotransferase cDNAs. Biochemical and Biophysical Research Communications. 195(1). 120–127. 76 indexed citations

Zhu, Xiaoyi, M Veronese, Lloyd Sansom, & Michael E. McManus. (1993). Molecular Characterization of a Human Aryl Sulfotransferase cDNA. Biochemical and Biophysical Research Communications. 192(2). 671–676. 60 indexed citations

Veronese, M, C. J. Doecke, Peter I. Mackenzie, et al.. (1993). Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily. Biochemical Journal. 289(2). 533–538. 118 indexed citations

10.

Birkett, Donald, Peter I. Mackenzie, M Veronese, & John O. Miners. (1993). In vitro approaches can predict human drug metabolism. Trends in Pharmacological Sciences. 14(8). 292–294. 73 indexed citations

11.

Tassaneeyakul, Wichittra, M Veronese, D. J. Birkett, et al.. (1992). Co-regulation of phenytoin and tolbutamide metabolism in humans.. PubMed. 34(6). 494–8. 38 indexed citations

12.

Veronese, M & Stuart McLean. (1991). Debrisoquine oxidation polymorphism in a Tasmanian population. European Journal of Clinical Pharmacology. 40(5). 529–532. 9 indexed citations

13.

Veronese, M & Stuart McLean. (1991). Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype. European Journal of Clinical Pharmacology. 40(6). 547–552. 12 indexed citations

14.

Turteltaub, Kenneth W., Mark G. Knize, Michael H. Buonarati, et al.. (1990). Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes. Carcinogenesis. 11(6). 941–946. 36 indexed citations

15.

McManus, Michael E., Wendy Burgess, M Veronese, et al.. (1990). Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.. PubMed. 50(11). 3367–76. 257 indexed citations

16.

Veronese, M, et al.. (1987). Experimental studies in vitro and in vivo on the mutagenicity of flavoxate.. PubMed. 37(5). 528–31. 2 indexed citations

17.

Veronese, M, et al.. (1985). Formation of reactive metabolites of phenacetin in humans and rats. Xenobiotica. 15(11). 929–940. 19 indexed citations

18.

Veronese, M, et al.. (1985). Mutagenicity studies on denzimol, a new anticonvulsant drug.. PubMed. 35(5). 793–6.

19.

Veronese, M, et al.. (1985). [Mutagenesis of efloxate tested in vitro and in vivo].. PubMed. 124(3). 124–30. 1 indexed citations

20.

Veronese, M, et al.. (1974). Urinary excretion in the rat of nifurpipone (NP) and of nitrofurantoin (NTF) administered by different routes.. PubMed. 24(1). 39–43. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact